Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-355
Closed -$26K 1078
2021
Q1
$26K Buy
355
+205
+137% +$15.6K ﹤0.01% 1080
2020
Q4
$11K Hold
150
﹤0.01% 1174
2020
Q3
$10K Sell
150
-209
-58% -$13.2K ﹤0.01% 1082
2020
Q2
$20K Buy
359
+54
+18% +$2.65K ﹤0.01% 1059
2020
Q1
$12K Hold
305
﹤0.01% 1029
2019
Q4
$16K Buy
305
+150
+97% +$7.47K ﹤0.01% 974
2019
Q3
$8K Sell
155
-2
-1% -$98 ﹤0.01% 1082
2019
Q2
$8K Hold
157
﹤0.01% 1082
2019
Q1
$8K Hold
157
﹤0.01% 1026
2018
Q4
$6K Hold
157
﹤0.01% 1017
2018
Q3
$6K Hold
157
﹤0.01% 1126
2018
Q2
$6K Sell
157
-202
-56% -$7.77K ﹤0.01% 1085
2018
Q1
$13K Hold
359
﹤0.01% 856
2017
Q4
$15K Sell
359
-5
-1% -$199 ﹤0.01% 734
2017
Q3
$13K Buy
+364
New +$14.7K ﹤0.01% 640

Other funds holding HOLX

Valeo Financial Advisors's HOLX Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Hologic (HOLX) in Q2 2021, closing a stake of 355 shares — an estimated $26K sold.

Valeo Financial Advisors first reported a position in HOLX in Q3 2017 and held it in 15 quarters. The position peaked at $26K in Q1 2021. 625 funds tracked by Wall St. Rank hold HOLX as of Q2 2021.

  • Valeo Financial Advisors reported no remaining Hologic position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 355 Hologic shares in Q2 2021, an estimated $26K.
  • Valeo Financial Advisors first reported a position in Hologic in Q3 2017 and held it in 15 quarters.
  • Valeo Financial Advisors's Hologic position peaked at $26K in Q1 2021.
  • 625 funds tracked by Wall St. Rank held Hologic as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.